— Know what they know.
Not Investment Advice
Also trades as: MOR.DE (XETRA) · $vol 5M · MPSYF (OTC) · $vol 0M · MOR.SW (SIX)

MOR NASDAQ

MorphoSys AG
1W: +0.0% 1M: +0.4% 3M: +6.1% 1Y: +152.8% 3Y: +43.0% 5Y: -37.6%
$18.96
Last traded 2024-08-09 — delisted
NASDAQ · Healthcare · Biotechnology · $2.9B mcap · 902436 float · 9.19% daily turnover

Cash Flow Trends

Operating Cash Flow
-$296M +19.3% ▲
Capital Expenditures
$3M +81.1% ▲
5Y CAGR: +3.1%
Free Cash Flow
-$299M +21.8% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$244M -187.4% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2019FY2020FY2021FY2022FY2023
— Operating Activities —
Net Income-$103M$98M-$514M-$151M-$190M
Depreciation & Amort.$6M$8M$10M$11M$11M
Stock-Based Comp.$7M$9M$3M$4M$27M
Change in Working Capital$18M$13M-$113M-$51M$7M
Other Non-Cash Items-$4M-$17M$210M-$347M-$150M
Operating Cash Flow-$80M$35M-$481M-$367M-$296M
— Investing Activities —
Capital Expenditures-$4M-$49M-$26M-$15M-$3M
Acquisitions (Net)$562K$2M-$1.2B$0$5M
Investment Purchases-$290M-$1.7B-$2.2B-$1.9B-$3.2B
Investment Sales$372M$916M$2.6B$2.2B$3.1B
Other Investing-$452K$1M$2M$4M$18M
Investing Cash Flow$79M-$880M-$831M$345M$15M
— Financing Activities —
Net Debt Issuance$0$0$0$0$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$353K$907M$1.3B$311M$43M
Financing Cash Flow$353K$907M$1.3B$311M$43M
Net Change in Cash-$1M$65M$13M$279M-$244M
Cash End of Period$44M$110M$123M$402M$158M
Free Cash Flow-$84M-$14M-$508M-$382M-$299M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms